GSK’s Dovato hits endpoints in late-stage study

08:38 EDT 10 Jul 2019 | PharmaTimes

In a Phase III study the drug combo was as effective in controlling HIV-1 as a Vemlidy combo.

Original Article: GSK’s Dovato hits endpoints in late-stage study


More From BioPortfolio on "GSK’s Dovato hits endpoints in late-stage study"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...